HKD
AMTD Digital Inc - ADR
-24.37%
$9.48 - $7.17
Feb 8th 2023 - Mar 22nd 2023
Mar, 8, 2023
Results have been good.
Feb, 3, 2023
We have achieved tremendous growth since launch Sp... See more
PALI
Palisade Bio Inc
-19.56%
$2.25 - $1.81
Feb 7th 2023 - Mar 21st 2023
Divihomes is Now Live
Check out our new advanced search tool that can help you find the best home services in your area.
Search & Match
Instant Communication
Unbiased Reviews
100% Free
BCRX
Biocryst Pharmaceuticals Inc.
-23.50%
$10.68 - $8.17
Feb 7th 2023 - Mar 21st 2023
Feb, 7, 2023
Long term Bcrx should climb quarter after quarter ... See more
Jan, 12, 2023
Positive news with the early results of the new Fa... See more
Mar, 8, 2023
Results have been good.
Feb, 3, 2023
We have achieved tremendous growth since launch SpiderNet ecosystem solutions business in December 2017 as a result continued expansion and monetization of AMTD SpiderNet ecosystem.
Feb, 3, 2023
We have achieved tremendous growth since the launch of our SpiderNet ecosystem solutions business in December 2017 as a result of the continued expansion and monetization of AMTD SpiderNet ecosystem.
Feb, 3, 2023
$HKD Earnings results or not, something explosive is about to happen here!
Jan, 7, 2023
$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.
Dec, 28, 2022
$HKD positive financial results for YGMZ price at the bottom great opportunity
Oct, 25, 2022
$HKD sky-rocketing a full quarter!! !
Oct, 13, 2022
$HKD not even worried for some reason … I got til December …will double my position this month if she goes under $30…market is shit this quarter this seems like a better bet 😂😂😂🤷🏾♀️
Oct, 11, 2022
It’s been a while since $hkd has had a good regular hours run, lately I’ve been noticing with these stocks that run 60%, the following day they tend to repeat themselves with even better results.
Jan, 2, 2023
They voluntarily suspended phase 3 bc they are seeing such a good results.
Feb, 7, 2023
Long term Bcrx should climb quarter after quarter until they align with projections billion plus!
Jan, 12, 2023
Positive news with the early results of the new Factor D molecule 10013.
Jan, 9, 2023
$BCRX 10% growth quarter over quarter considering flat q1 (as noted with ins payout sched) puts us at 326mil for the year.
Jan, 9, 2023
Relative strength to SPY past 6 weeks, high growth 8 quarters straight.
Jan, 9, 2023
$BCRX 10.5 is the new high for this first quarter.
Jan, 9, 2023
$BCRX so they hit their Q4 numbers, had stellar phase IA results and guided for a 70Mil increase in revenue in 202e.
Jan, 9, 2023
$BCRX sales doubled 4 quarter 70.7 million + 53% year over year..
Jan, 4, 2023
Result - volume up about 36.5% over a normal day.
Dec, 29, 2022
But, with our management, our scientists, and our derisked ORLADEYO keeping the revenues incoming and growing quarter after quarter after quarter.
Dec, 15, 2022
Prem results in q1 and it will beat any drug in the mkt.